Natural and synthetic isoflavones in the prevention and treatment of chronic diseases

Calcified Tissue International

Volumn 61, Issue SUPPL. 1, 1997, Pages

  Brandi, M L ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Chronic diseases; Isoflavones; Phytoestrogens

Indexed keywords

BIOCHANIN A; FORMONONETIN; IPRIFLAVONE; ISOFLAVONE; PHYTOESTROGEN;

BONE ATROPHY; CHRONIC DISEASE; CONFERENCE PAPER; DISEASE ACTIVITY; ENZYME INHIBITION; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEIN ISOLATION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANIMALS; CORONARY DISEASE; DIET; DISEASE MODELS, ANIMAL; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; ISOFLAVONES; NEOPLASMS; OSTEOPOROSIS, POSTMENOPAUSAL; PHYTOESTROGENS; PLANT PREPARATIONS; PLANTS; RECEPTORS, ESTROGEN; SOYBEANS;

EID: 0030752384     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900376     Document Type: Conference Paper

References (42)

1. Bradbury RB, White DE (1954) Estrogens and related substances in plants. In: Harris RS, Marrian GF, KV Thimann (eds) Vitamins and hormones. Academic Press, New York, pp 207-233
2. Farnsworth NR, Bingel AS, Cordell AS, Crane FA, Fong HHS (1975) Potential value of plants as sources of new antifertility agents. J Pharm Sci 64:717-754
3. Kondo H, Nakajima S, Yamamoto N, Okura A, Satoh F, Suda H, Okanishi M, Tanaka N (1990) BE-14384 substances, new specific estrogen-receptor binding inhibitors. Production, isolation structure determination and biological properties. J Antibio (Tokyo) 43:1533-1542
4. Martin PM, Horowitz KB, Ryan DS, McGuire WL (1978) Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 103:1860-1867
5. Setchell KDR, Borriello SP, Hulme P, Kirk DN, Axelson M (1984) Non-steroidal estrogens of dietary origin: possible role hormone-dependent disease. Am J Clin Nutr 40:569-578
6. Clark JH, Hardin JM, Upchurch S, Eriksson H (1978) Hetrogeneity of estrogen binding sites in the cytosol of rat uterus. J Biol Chem 253:7630-7634
7. 3H]-estradiol binding in rat uterine nuclei. J Biol Chem 258: 11663-11671
8. Bickoff EM, Livingston AL, Booth AN (1964) Tricin from alfalfa-isolation and physiological activity. J Pharm Sci 53: 1411-1412
9. Shutt DA, Cox RI (1972) Steroid and phytoestrogen binding to sheep uterine receptors in vitro. J Endocrinol 52:299-310
10. Cheng E, Yoder L, Story CD, Burroughs W (1954) Estrogenic activity of some isoflavone derivates. Science 120:575-577
11. Bickoff EM, Livingston AL, Hendrickson AP, Booth AN (1962) Relative potencies of several estrogen-like compounds found in forrages. Agric Food Chem 10:410-112
12. Bickoff EM, Booth AN, Lyman RL, Livingston AL, Thompson CR, DeEDS F (1957) Coumestrol, a new estrogen isolated from forage crops. Science 126:969-970
13. Shemesh M, Lindner HR, Ayalon N (1972) Affinity of rabbit uterine oestradiol receptor for phyto-oestrogens and its use in a competitive protein-binding radioassay for plasma coumestrol. J Reprod Fert 29:1-9
14. Adlercreutz H, van der Wildt J, Kilzel J, Attalla H, Wahala K, Makela T, Hase T, Fotsis T (1995) Lignan and isoflavonoid conjugates in human urine. J Steroid Biochem Mol Biol 52: 97-103
15. Setchell KDR, Gasselni SJ, Welsh MB, Johnston JO, Balistrieri WF, Kramer LW, Dresser BL, Tarr MJ (1987) Dietary estrogens - a probable cause of infertility and liver disease in captative cheetahs. Gastroenterology 93:225-233
16. Barnes S, Grubbs C, Setchell KDR, Carlson J (1990) Soybeans inhibit mammary tumors in models of breast cancer. In: Pariza MW (ed) Mutagens and carcinogens in the Diet. Wiley-Liss, New York, pp 239-253
17. Adlercreutz M, Musey PI, Fotsis T, Bannwart C, Wahala K, Makela T, Brunow G, Hase T (1986) Identification of lignans and phyto-oestrogens in urine of chimpanzees. Clin Chim Acta 158:47-154
18. Shino M (1985) Pharmacokinetic study of ipriflavone (TC80) by oral administration in healthy male volunteers. Jpn Pharmacol Ther 13:7223-7233
19. Terpstra AH, Wers CE, Ferris JT, Schouten JA, van der Veen EA (1984) Hypocholesterolemic effect of dietary soy protein versus casein in rhesus monkeys (Macaca mulatta). Am J Clin Med 39:1-7
20. Lovati MR, Manzoni C, Canavesi A, Sirtori M, Vaccarino V, Marchi M, Gaddi G, Sirtori CR (1987) Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients. J Clin Invest 80:1498-1502
21. Clarkson TB, Anthony MS, Hughes CL (1995) Estrogenic soybean isoflavones and chronic disease. Risks and benefits. Trend End Met 6:11-16
22. Anderson JJB, Ambrose WW, Garner SC (1995) Biphasic effects of genistein on bone tissue in ovariectomized rat models. 3rd Intl Con on Phytoestrogens. Little Rock, Arkansas, USA; 3-6 December
23. Hann TJ (1978) Corticosteroid-induced osteopenia. Arch Intern Med 138:882-885
24. Yamazaki I, Shino A, Shimizu Y, Tsukuda R, Shirakawa Y, Kinoshita M (1986) Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats. Life Sci 38:951-958
25. Shino A, Matsuo T, Tsuda M, Yamazaki I, Tsukuda R, Kitazaki T, Shiota K, Yoshida K (1986) Effect of ipriflavone on bone and mineral metabolism in the streptozotocin diabetic rats. J Bone Miner Metab 3:27-37
26. Suda A (1987) Effect of parathyroid hormone on parietal bones of rats, and effect of ipriflavone. J Bone Miner Metab 5:51-56
27. Takenaka M, Nakata M, Tomita M, Nakagawa T, Tsuboi S, Fujita T (1992) Effect of ipriflavone on the development of experimental osteopathy in rats induced by low calcium, low vitamin D diet. In: Vitamin D, chemical, biochemical and clinical endocrinology of calcium metabolism. Walter de Gruyter & Co., Berlin-New York, pp 607-609
28. Foldes I, Rapcsak M, Szoor A, Gyarmati J, Szilagy T (1988) The effect of ipriflavone treatment on osteoporosis induced by immobilization. Acta Morphol Hung 36:79-93
29. Bonucci E, Ballanti P, Martelli A, Mereto E, Brambilla G, Bianco P, Bufalino L (1992) Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of rats. Calcif Tissue Int 50:314-319
30. Ozawa H, Nakamura H, Irie K, Irie M (1992) Histochemical and fine structural study of bone of ipriflavone-treated rats. Calcif Tissue Int 51 (suppl 1):s21-s26
31. Civitelli R, Abbasi-Jarhomi SH, Halstead LR, Dimaragonas A (1995) Ipriflavone improves bone density and biomechanical properties of adult male rat bones. Calcif Tissue Int 56:215-219
32. Fujita T, Mizuno K, Ono K, Inoue T, Shimazu A, Morii H, Ohata M, Takahashi H, Yoshida Y (1985) A dose-finding study on TC-80 (ipriflavone) in osteoporosis. Prog Med 5: 2959-2963
33. Gambacciani M, Spinetti A, Cappagli B, Taponeco F, Felipetto R, Parrini D, Cappelli N, Fioretti P (1993) Effects of ipriflavone administration on bone mass and metabolism in ovariectomized women. J Endocrinol Invest 16:333-337
34. Gambacciani M, Spinetti A, Piaggesi L, Cappagli B, Taponeco F, Manetti P, Weiss C, Teti GC, La Commare P, Facchini V (1994) Ipriflavone prevents the bone mass reduction in premenopausal women treated with gonadotropin hormone-releasing hormone agonists. Bone Miner 26:19-26
35. Agnusdei D, Adami S, Cervetti R, Crepaldi G, Di Munno O, Fantasia L, Isaia GC, Letizia G, Ortolani S, Passen M, Serni U, Vecchiet L, Gennari C (1992) Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosis. Bone Miner 19:S43-S48
36. Agnusdei D, Camporeale A, Zacchei F, Gennari C, Baroni MC, Costi D, Biondi M, Passen M, Ciacca A, Sbrenna C, Falsettini E, Ventura A (1992) Effects of ipriflavone on bone mass and bone remodeling in patients with established postmenopausal osteoporosis. Curr Ther Res 51:82-91
37. Valente M, Bufalino L, Castiglione GN, D'Angelo R, Mancuso A, Galoppi P, Zichella L (1994) Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass. Calcif Tissue Int 54:377-380
38. Passeri M, Biondi M, Costi D, Dall'Aglio E, Pedrazzoni M, Bufalino L, Castiglione GN, Abate G (1995) Effects of 2-year therapy with ipriflavone in elderly women with established osteoporosis. Ital J Mineral Electrolyte Metab 9:137-144
39. Agnusdei D, Camporeale A, Gonnelli S, Gennari C, Baroni MC, Passen M (1992) Short-term treatment of Paget's disease of bone with ipriflavone. Bone Miner 19:S35-S42
40. Mazzuoli GF, Romagnoli E, Carnevale L, Scarda A, Scarnecchia M, Pacitti MT, Rosso R, Minisola S (1992) Effects of ipriflavone on bone remodeling in primary hyperparathyroidism. Bone Miner 19:S27-S33
41. Yamazaki I (1986) Effects of ipriflavone on the response of uterus and thyroid to estrogen. Life Sci 38:757-764
42. Melis GB, Paoletti AM, Cagnacci A, Bufalino L, Spinetti A, Gambacciani M, Fioretti P (1992) Lack of any estrogenic effect of ipriflavone in postmenopausal women. J Endocrinol Invest 15:755-761